Markets:

Overview

News

Currencies

International

Treasuries

Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

0.5499 -0.0601 (-9.85%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aptevo Therapeutics Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Aptevo Therapeutics and Alligator Bioscience to Present Additional Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at SITC 2024

October 29, 2024

Via ACCESSWIRE

Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss ↗

October 23, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 23, 2024

Via Benzinga

Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket ↗

October 23, 2024

Via Benzinga

Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated

August 13, 2024

Via ACCESSWIRE

Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA

May 14, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 22, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 21, 2024

Via Benzinga

Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket ↗

October 21, 2024

Via Benzinga

Aptevo Therapeutics Announces Closing of $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules

September 18, 2024

Via ACCESSWIRE

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗

September 17, 2024

Via Benzinga

Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules

September 16, 2024

Via ACCESSWIRE

Aptevo Therapeutics and Alligator Bioscience Announce Data from Phase 1 ALG.APV-527 Monotherapy Trial Showing 60% of Evaluable Patients Achieved Stable Disease in Solid Tumor Study

September 16, 2024

Via ACCESSWIRE

Aptevo Therapeutics and Alligator Bioscience to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types, at ESMO Congress 2024

September 13, 2024

Via ACCESSWIRE

APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q2 2024 ↗

August 08, 2024

APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Aptevo Therapeutics Reports 2Q 2024 Financial Results and Provides a Business Update

August 08, 2024

Via ACCESSWIRE

Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 18, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

July 18, 2024

Pre-market stock movers are worth diving into this morning and we have all of the hottest news worth checking out on Thursday!

Via InvestorPlace

Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket ↗

July 18, 2024

Via Benzinga

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 17, 2024

Via Benzinga

Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

July 17, 2024

Via Benzinga

Aptevo Therapeutics Announces Closing of $2.75 Million Offering

July 01, 2024

Via ACCESSWIRE

Aptevo Therapeutics Announces $2.75 Million Offering Priced At-the-Market Under Nasdaq Rules

June 28, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 17, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

June 17, 2024

We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning!

Via InvestorPlace

Aptevo Participating in the BIO International Convention

June 03, 2024

Via ACCESSWIRE

APVO Stock Earnings: Aptevo Therapeutics Beats EPS for Q1 2024 ↗

May 08, 2024

APVO stock results show that Aptevo Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update

May 08, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 03, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 02, 2024

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.